UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) September 19, 2005
SUNWIN INTERNATIONAL
NEUTRACEUTICALS, INC.
(Exact name of registrant as specified in its charter)
Nevada 033-10456 56-2416925
- ------------------------------ --------------------- ----------------------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
6 Youpeng Road, Qufu, Shandong, China 273100
- ----------------------------------------------- ----------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (86) 537-4424999
------------------------
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
[ ] Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c))
ITEM 2.02 RESULTS OF OPERATION AND FINANCIAL CONDITION
On September 19, 2005, we issued a press release announcing our July 31, 2005
quarter end financial results. On September 23, 2005, we issued a press release
clarifying and correcting certain information contained in the September 19,
2005 press release. A copy of these press release are attached hereto as Exhibit
99.1 and 99.2 and are incorporated herein by reference.
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS
(c) Exhibits
99.1 Press Release dated September 19, 2005.
99.2 Press Release dated September 23, 2005.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
SUNWIN INTERNATIONAL NEUTRACEUTICALS, INC.
Date: September 23, 2005 By: /s/ Dongdong Lin
-----------------
Dongdong Lin
Chief Executive Officer